Literature DB >> 15777212

The chemistry and pharmacology of tetrahydropyridines.

N N Mateeva1, L L Winfield, K K Redda.   

Abstract

Tetrahydropyridine (THP) moiety is a part of many biologically active systems. The discovery of the neurotoxic properties of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as well as numerous alkaloids, prompted extensive research on the synthesis and pharmacological properties of these compounds. The goal was extending the database for structure-activity relationship (SAR) studies. Consequently, many promising drug candidates were designed and a lot more are under clinical study. The current paper reviews the most popular approaches for the synthesis of THP derivatives. The pharmacological characteristics of some THP derivatives are summarized together with composite of the data from their in vitro, ex vivo and in vivo assays.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15777212     DOI: 10.2174/0929867310504050551

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  12 in total

1.  Synthesis of 1-(Substituted Phenylcarbonyl/sulfonylamino)-1,2,3,6-tetrahydropyridine-5-carboxylic acid diethylamides as Potential Anti-inflammatory Agents.

Authors:  Madhavi Gangapuram; Kinfe K Redda
Journal:  J Heterocycl Chem       Date:  2006-05-01       Impact factor: 2.193

2.  Regio- and stereoselective 1,2-dihydropyridine alkylation/addition sequence for the synthesis of piperidines with quaternary centers.

Authors:  Simon Duttwyler; Shuming Chen; Colin Lu; Brandon Q Mercado; Robert G Bergman; Jonathan A Ellman
Journal:  Angew Chem Int Ed Engl       Date:  2014-03-06       Impact factor: 15.336

3.  Enhancing a CH-π Interaction to Increase the Affinity for 5-HT1A Receptors.

Authors:  Jean-François Liégeois; Marc Lespagnard; Elsa Meneses Salas; Floriane Mangin; Jacqueline Scuvée-Moreau; Sébastien Dilly
Journal:  ACS Med Chem Lett       Date:  2014-01-29       Impact factor: 4.345

4.  Regio- and Diastereoselective Synthesis of Highly Substituted, Oxygenated Piperidines from Tetrahydropyridines.

Authors:  Shuming Chen; Brandon Q Mercado; Robert G Bergman; Jonathan A Ellman
Journal:  J Org Chem       Date:  2015-06-22       Impact factor: 4.354

5.  SYNTHESIS OF N-SUBSTITUTED CARBONYLAMINO-1,2,3,6-TETRAHYDROPYRIDINES AS POTENTIAL ANTI-INFLAMMATORY AGENTS.

Authors:  Mohammad A Ghaffari; Tiffany W Ardley; Madhavi Gangapuram; Kinfe K Redda
Journal:  Synth Commun       Date:  2011-06-29       Impact factor: 2.007

6.  Highly diastereoselective synthesis of tetrahydropyridines by a C-H activation-cyclization-reduction cascade.

Authors:  Simon Duttwyler; Colin Lu; Arnold L Rheingold; Robert G Bergman; Jonathan A Ellman
Journal:  J Am Chem Soc       Date:  2012-02-22       Impact factor: 15.419

7.  Synthesis and biological evaluation of substituted N-[3-(1H-pyrrol-1-yl)methyl]-1,2,5,6-tetrahydropyridin-1-yl]benzamide/benzene sulfonamides as anti-inflammatory agents.

Authors:  Madhavi Gangapuram; Elizabeth Mazzio; Suresh Eyunni; Karam F A Soliman; Kinfe K Redda
Journal:  Arch Pharm (Weinheim)       Date:  2014-03-02       Impact factor: 3.751

8.  Catalytic Enantioselective Synthesis of Guvacine Derivatives through [4 + 2] Annulations of Imines with α-Methylallenoates.

Authors:  Qihai Xu; Nathan J Dupper; Andrew J Smaligo; Yi Chiao Fan; Lingchao Cai; Zhiming Wang; Adam D Langenbacher; Jau-Nian Chen; Ohyun Kwon
Journal:  Org Lett       Date:  2018-09-24       Impact factor: 6.072

9.  Tandem dinucleophilic cyclization of cyclohexane-1,3-diones with pyridinium salts.

Authors:  Mostafa Kiamehr; Firouz Matloubi Moghaddam; Satenik Mkrtchyan; Volodymyr Semeniuchenko; Linda Supe; Alexander Villinger; Peter Langer; Viktor O Iaroshenko
Journal:  Beilstein J Org Chem       Date:  2013-06-10       Impact factor: 2.883

Review 10.  Convergent Synthesis of Diverse Tetrahydropyridines via Rh(I)-Catalyzed C-H Functionalization Sequences.

Authors:  Tehetena Mesganaw; Jonathan A Ellman
Journal:  Org Process Res Dev       Date:  2014-08-29       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.